Hematology
Conference Coverage
High VTE recurrence risk persists for at least 3 years
The risk of recurrence following an initial episode of venous thromboembolism is highest in the first 3 months, but remains high for up to 3 years...
News
Extended warfarin delays return of unprovoked pulmonary embolism
Key clinical point: Eighteen additional months of warfarin therapy delays the recurrence of unprovoked pulmonary embolism. Major finding: During...
Conference Coverage
Idarucizumab reverses dabigatran’s anticoagulant effects
Key clinical point: The investigational monoclonal antibody idarucizumab reversed the anticoagulant effects of dabigatran. Major finding:...
Commentary
MRSA coverage in cellulitis treatment
Should cellulitis treatment always include an antibiotic that covers MRSA?
News
FDA: SGLT2 inhibitors may lead to ketoacidosis
News
New guidelines address hypopituitarism in TBI
Key clinical point: Screening for and treating pituitary hormone deficiencies is recommended for people with complicated mild traumatic brain...
News
More than 75% with sickle cell crises don’t get hydroxyurea
Key clinical point: More than 75% of adults with sickle cell anemia who have frequent pain crises fail to get hydroxyurea therapy as recommended....
News
Unrecognized diabetes common in acute MI
Key clinical point: Many patients presenting with acute MI had unrecognized diabetes and, in most cases, that DM remained undiagnosed, untreated,...